Palomino Laboratories (PALX) Notes Payables (2022 - 2025)

Palomino Laboratories has disclosed Notes Payables across 4 years of filings, most recently posting $318750.0 for Q3 2025.

• In Q3 2025, Notes Payables rose 144.73% year-over-year to $318750.0; the TTM figure through Sep 2025 stood at $318750.0 (up 144.73% YoY), while the FY2024 annual figure was $275000.0, up 245.64% from the prior year.
• Notes Payables came in at $318750.0 for Q3 2025 at Palomino Laboratories, up from $20000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $318750.0 in Q3 2025 to a low of $304.0 in Q4 2022.
• Average Notes Payables over 4 years is $131142.8, with a median of $94883.5 recorded in 2023.
• Year-over-year, Notes Payables jumped 26072.04% in 2023 and slumped 81.85% in 2025.
• Over 4 years, Notes Payables stood at $304.0 in 2022, then jumped by 26072.04% to $79563.0 in 2023, then soared by 245.64% to $275000.0 in 2024, then advanced by 15.91% to $318750.0 in 2025.
• Per Business Quant data, the three most recent Notes Payables figures were $318750.0 in Q3 2025, $20000.0 in Q2 2025, and $275000.0 in Q1 2025.